Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

3 The third‐generation iteration of the Pipeline Embolization Device (PED) incorporates Shield technology, a phosphorylcholine coating designed to reduce thrombogenicity via mimicry of native cell membranes.4 One patient had a new intraparenchymal hemorrhage, but no appreciable deficit.

Embolism 40

Embolism Aneurysm Hemorrhage Stent 40

Journal of the American Heart Association

JANUARY 31, 2024

The primary outcomes were ischemic stroke, systemic embolic events, and hospitalization for major bleeding. The secondary outcomes were intracranial hemorrhage, hospitalization for gastrointestinal bleeding, all‐cause mortality, and a composite outcome. The median follow‐up duration was 2.4 1.06];P=0.11).

Atrial Fibrillation 40

Atrial Fibrillation Tricuspid Embolism Hemorrhage 40

Journal of the American Heart Association

NOVEMBER 28, 2023

We searched the PubMed, EMBASE, and Cochrane databases for randomized controlled trials that compared thromboembolic or bleeding outcomes between a direct oral anticoagulant (DOAC) and a vitamin K antagonist (VKA) and reported outcomes for patients aged ≥75 years with atrial fibrillation. prospero/.

Atrial Fibrillation 40

Atrial Fibrillation Embolism Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionSubarachnoid Hemorrhage (SAH) resulting from the spontaneous rupture of an aneurysm is a rare and highly debilitating condition. The AKI and non‐AKI groups were assessed for baseline clinical characteristics, interventions, complications, and outcomes.

Hemorrhage 40

Hemorrhage Aneurysm Cardiac Arrest Myocardial Infarction 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

However, IVT's efficacy on stent retriever (SR) and aspiration thrombectomy (ASP) outcomes specifically remain unclear. Moreover, our results indicate that administration of IVT before MT may improve certain outcomes based on the used first‐line MT technique. ResultsWe included four randomized controlled trials with 1176 patients.

Thrombolysis 40

Thrombolysis Outcomes Embolism Stent 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Cases of unruptured intracranial aneurysms (UIA) are estimated to affect roughly 3% of the general population and aneurysmal subarachnoid hemorrhage (aSAH) have an incidence of 8 to 9 people per 100,000. The subjects were followed for 6 months (‐4 months/+6 months).

Aneurysm 40

Aneurysm Embolism Stent Stents 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionThe Pipeline Embolization Device (PED) is commonly used for intracranial aneurysm treatment. This review and meta‐analysis aimed to assess the long‐term outcomes of PED treatment for unruptured intracranial aneurysms (UIA).MethodsA Secondary outcomes included long‐term complications.

Aneurysm 40

Aneurysm Outcomes Embolism Hemorrhage 40

Journal of the American Heart Association

FEBRUARY 29, 2024

We examined potential causal associations between schizophrenia and a range of atherosclerotic, embolic, and hemorrhagic stroke outcomes.Methods and ResultsTwo‐sample Mendelian randomization analyses were conducted. Little evidence of associations with the other stroke subtypes was found.

Stroke 40

Stroke Strokes Hemorrhage Embolism 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Embolization is now a well‐established endovascular technique to treat traumatic hemorrhagic injuries(4). On arrival at the hospital, the patient was hemodynamically stable with no ongoing hemorrhage or respiratory distress. Retrograde filling of the internal maxillary artery was noted.

Embolism 40

Embolism Hemorrhage Hospital Strokes 40

Stroke Journal

FEBRUARY 1, 2024

The primary outcome was an ischemic (stroke or systemic embolus) or hemorrhagic (ICH or major systemic hemorrhage) event observed within 30 days from the index stroke time of onset. No ischemic events were observed for Arm 1, and no hemorrhage events were observed for Arm 4. at the time of randomization.

Atrial Fibrillation 40

Atrial Fibrillation Stroke Strokes Hemorrhage 40

Circulation

JANUARY 24, 2024

The primary efficacy and safety outcomes were stroke or systemic embolic events (stroke/SEE) and major bleeding, respectively; secondary outcomes were ischemic stroke/SEE, intracranial hemorrhage, death, and the net clinical outcome (stroke/SEE, major bleeding, or death). interquartile range, 25.2–32.2)

Atrial Fibrillation 80

Atrial Fibrillation BMI Stroke Strokes 80

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionTo provide our single‐institution experience and outcome data with the WEB device in 51 patients treated for ruptured and unruptured intracranial aneurysms.MethodsOcclusion rates in a cohort of 51 patients treated with WEB were collected at time of procedure and at last follow‐up between the years 2019 and 2021.

Aneurysm 40

Aneurysm Embolism Hemorrhage Document 40

Stroke Journal

FEBRUARY 1, 2024

Outcomes have improved over time with advances in endovascular embolization. Patients were stratified based on radiographic outcomes: cured before the age of 18 (“pediatric-cured group”), cured after the age of 18, or not cured. Long-term functional outcomes were assessed using the modified Rankin Scale (mRS).

Pediatrics 40

Pediatrics Hemorrhage Embolism Congenital 40

Stroke Journal

FEBRUARY 1, 2024

Our primary study outcome was any stroke or major thrombotic event identified within 60 days of OHSS diagnosis in HCUP or during the index admission for OHSS in NIS. The low rate of outcome events after OHSS seen in each of our population-level analyses increases the reliability of these study results.

Thrombosis 40

Thrombosis Inpatient Embolism Myocardial Infarction 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Eventually, the PSA of the Internal maxillary artery (IMAX) was embolized, resulting in resolution of the patient's symptoms.MethodsCase ReportResultsA 75‐year‐old male with a history of atrial fibrillation on Eliquis presented to the emergency department after sustaining a gunshot wound to the left face.

Aneurysm 40

Aneurysm Stroke Strokes Embolism 40

DAIC

FEBRUARY 13, 2024

mismatch volume of ≥15 mL, and ischemic core volume TIMELESS is the first study to show that an intravenous thrombolytic can be given up to 24 hours after LKW without an increase in brain hemorrhage. Improved Stroke Outcomes Following Implementation of RapidAI Platform at Ascension-Illinois, by Malisch et.

Stroke 111

Stroke Strokes Embolism Hospital 111

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

1] This might result in worse outcomes, despite successful recanalization, from hyper‐ or hypoperfusion with a risk for hemorrhagic conversion or larger stroke volume, respectively. An Embolic etiology was suspected and a 20‐minuteTCD was done for spontaneous emboli detection on bilateral middle cerebral arteries (MCA).

Stroke 40

Stroke Strokes Blood Pressure Document 40

EMS 12-Lead

MARCH 30, 2024

The receiving staff suspects pulmonary embolism due to S1Q3T3 on the ECG and administers TPA. The patient did have massive pulmonary emboli, but he also had profound intraventricular and subarachnoid hemorrhages. The patient was ultimately discharged with a poor neurologic outcome. On ED arrival ROSC is achieved.

Cardiac Arrest 124

Cardiac Arrest Pacemaker Pulmonary Bradycardia 124

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Secondary endpoints included good functional outcomes (mRS 0‐2) at Day 90, revascularization time, first line and first pass mTICI ≥2b, occurrence of procedure‐related SAEs, vasospasm involving the accessed vascular tree, embolization to new territories (ENTs), symptomatic intracerebral hemorrhage (sICH) within 24 hours and mortality at Day 90.MethodsSOFAST

Stroke 40

Stroke Strokes Embolism Stent 40

Stroke Journal

FEBRUARY 1, 2024

Our study aimed to compare outcomes of patients diagnosed with CVT within 2 weeks of COVID infection compared to those without COVID-19.Methods:Adult All-cause mortality was the primary outcome. Stroke, Volume 55, Issue Suppl_1 , Page AWMP49-AWMP49, February 1, 2024. vs 13.6%; HR=1.51; 95% CI=1.04-2.20) 2.20) but not at three months.

COVID-19 40

COVID-19 Outcomes Thrombosis Embolism 40

DAIC

JANUARY 22, 2024

Kown, Asan Medical Center, Seoul, Korea Golden Bridge II Effect of an Artificial Intelligence-Based Clinical Decision Support System on Stroke Care Quality and Outcomes in Patients With Acute Ischemic Stroke : A Cluster-Randomized Clinical Trial: Zixiao Li, Beijing Tiantan Hospital, Capital Medical University, Beijing, China Friday, Feb.

Stroke 100

Stroke Strokes Hospital Thrombolysis 100

Stroke: Vascular and Interventional Neurology

FEBRUARY 5, 2024

The second most common treatment modality was endovascular embolization (36.9%). Eleven patients experienced intracranial hemorrhage as a complication of CPA; 10 of the 11 patients underwent decompressive craniectomy. These studies consisted of 41 case reports, 6 case series, and 1 retrospective cohort study.

Embolism 40

Embolism Ischemia Hemorrhage Strokes 40

Dr. Smith's ECG Blog

APRIL 8, 2015

Also consider non-hemorrhagic volume depletion, dehydration : orthostatic vitals may uncover this [see Mendu et al. (3)]. Cardiac Syncope ("True Syncope") Independent Predictors of Adverse Outcomes condensed from multiple studies 1. These premonitory symptoms were negative predictors of adverse outcomes in EGSYS.

Arrhythmia 52

Arrhythmia Outcomes Risk Factors Chest Pain 52